Cerebellum’s Colgate-Palmolive CL Stock Holding History

Cerebellum’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$65K	Sell	845 -868	-51%	-$66.2K	0.3%	59
2020 Q2	$129K	Buy	+1,713	New	+$122K	0.09%	135
2019 Q4	$20K	Sell	294 -5,754	-95%	-$392K	0.01%	408
2019 Q3	$445K	Buy	6,048 +1,249	+26%	+$90.6K	0.29%	126
2019 Q2	$344K	Sell	4,799 -302	-6%	-$21.4K	0.28%	208
2019 Q1	$350K	Buy	+5,101	New	+$329K	0.3%	4
2018 Q3	–	Sell	-2,740	Closed	-$178K	–	438
2018 Q2	$178K	Sell	2,740 -11	-0.4%	-$720	0.3%	94
2018 Q1	$197K	Buy	2,751 +1,038	+61%	+$74.7K	0.25%	30
2017 Q4	$129K	Buy	+1,713	New	+$125K	0.09%	135

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Cerebellum's CL Position: Q3 2020 in Review

Cerebellum reduced its Colgate-Palmolive (CL) stake by 51% in Q3 2020, selling an estimated $66.2K and leaving 845 shares worth $65K. The position accounts for 0.3% of the portfolio, ranked #59.

Cerebellum first reported a position in CL in Q4 2017 and has held it in 9 quarters since. The position peaked at $445K in Q3 2019. 1,530 funds tracked by Wall St. Rank hold CL as of Q3 2020.

Cerebellum held 845 shares of Colgate-Palmolive worth $65K as of Q3 2020.
Cerebellum sold 868 Colgate-Palmolive shares in Q3 2020, an estimated $66.2K.
Colgate-Palmolive made up 0.3% of Cerebellum's portfolio in Q3 2020, its #59 holding.
Cerebellum first reported a position in Colgate-Palmolive in Q4 2017 and has held it in 9 quarters since.
Cerebellum's Colgate-Palmolive position peaked at $445K in Q3 2019.
1,530 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2020.

Based on Cerebellum's 13F filing for Q3 2020, filed 21 Oct 2020.